Syneron-Candela Introduces New Resolve Handpiece

Picoway tattoo removal

Syneron-Candela recently expanded its award-winning PicoWay platform to include a novel fractionated handpiece, the PicoWay Resolve, and a new ultra-short 785nm wavelength, the first of its kind in the aesthetic market utilizing a titanium sapphire laser for removal of blue and green inks. The platform now includes both fractional and nonfractional 532nm and 1064nm picosecond wavelengths for the treatment of benign pigmented lesions and tattoos, plus the 785nm wavelength, which further reduces pulse duration to address smaller ink particles. “The PicoWay’s picosecond technology generates a photoacoustic effect leading to laser-induced optical breakdown (LIOB) producing neocollagenesis,” says Vic A. Narurkar, M.D., dermatologist, founder, and director of the Bay Area Laser Institute in San Francisco. “There is less risk of thermal damage with picosecond laser pulses than with the nanosecond pulses delivered by other lasers.”

The Resolve handpiece for skin rejuvenation employs a unique holographic fractionator that delivers a matrix of focused microbeams with consistent intensity in each beam. The fractionated energy creates two-dimensional arrays of LIOBs in the superficial skin layer and can be focused in the epidermis using the 532nm wavelength, or in the upper papillary dermis using the 1064nm wavelength. This allows practitioners to address specific dyspigmentation and skin irregularities. Treatments are usually done without topical anesthetic and typically take only 15 to 30 minutes of the patient’s and practitioner’s time, depending on the size of the area(s) to be treated. “The Resolve is a genuine innovation and has quickly become one of the go-to devices in my practice,” says Philadelphia-based dermatologist and laser surgeon Eric F. Bernstein, M.D., MSE. “Tissue response with the Resolve is very different from any other laser I’ve used. Treatments are quick and require no topical anesthetic. There is almost no downtime and patients are extremely happy with the results. There is a little more redness with the 532nm wavelength than with the 1064nm, but it is significantly reduced within a few hours. In my hands this device has proved to be extremely safe and is quite effective.”

Suggested Articles

AAFPRS announced that Mary Lynn Moran, M.D. will serve as president of the organization for the 2019-2020 year term.

Dermatologists are the leading influencers for cosmetic procedures and skincare choices.

Unrealistic expectations of self-image driven by social media lead to disappointed clients.